Natera (NASDAQ:NTRA) PT Raised to $85.00

Natera (NASDAQ:NTRA – Free Report) had its price objective increased by BTIG Research from $75.00 to $85.00 in a research note published on Friday morning, Marketbeat.com reports. BTIG Research currently has a buy rating on the medical research company’s stock. Several other research firms have also recently weighed in on NTRA. StockNews.com initiated coverage on […]

Related Keywords

Montreal ,Quebec ,Canada ,Piper Sandler ,Sanfordc Bernstein ,Steven Leonard Chapman ,Raymond James ,Jonathan Sheena ,Metlife Investment Management ,Financial Services Group Inc ,York Mellon Corp ,Natera Company Profile ,Natera Inc ,Us Bancorp ,Free Report ,Moderate Buy ,Get Free Report ,Leonard Chapman ,New York Mellon Corp ,Services Group ,Montreal Can ,Natera Daily ,Natera ,Nasdaq Ntra ,Ontra ,Medical ,Boost Price Target ,Btig Research ,